Navigation Links
Aeterna Zentaris Reports Fourth Quarter and Full-Year 2007 Financial and Operating Results
Date:3/5/2008

inued operations 218 16,575 (259) 25,813

-------------------------------------------------------------------------

Net earnings (loss) for

the year (13,636) 39,101 (32,296) 33,390

-------------------------------------------------------------------------

-------------------------------------------------------------------------

Net earnings (loss) per

share from continuing

operations

Basic and diluted (0.26) 0.42 (0.61) 0.14

-------------------------------------------------------------------------

-------------------------------------------------------------------------

Net earnings (loss)

per share

Basic (0.26) 0.74 (0.61) 0.64

-------------------------------------------------------------------------

-------------------------------------------------------------------------

Diluted (0.26) 0.74 (0.61) 0.62

-------------------------------------------------------------------------

-------------------------------------------------------------------------

Weighted average number

of shares

Basic 53,182,803 52,694,868 53,182,803 52,099,290

Diluted 53,182,803 53,035,786 53,182,803 52,549,260

Issued and outstanding

shares 53,187,470 53,169,470

(In thousands of US dollars, except share

and per share data)

CONSOLIDATED BALANCE SHEET December December

31, 31,

Unaudited 2007 2006

-------------------------------------------------------------------------

----------------------------------
'/>"/>

SOURCE AETERNA ZENTARIS INC.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related biology technology :

1. AEterna Zentaris and Paladin Labs Announce Sale and Purchase of Miltefosine Rights
2. AEterna Zentaris Announces the Departure of SVP, Administrative and Legal Affairs
3. Aeterna Zentaris to Announce Fourth Quarter and Full-Year 2007 Financial and Operating Results on March 5, 2008
4. AEterna Zentaris to Present at the Upcoming Roth Capital Partners 20th Annual OC Growth Stock Conference in Dana Point, California
5. AEterna Zentaris Reports First Patients Treated with Anti-Cancer Compound AEZS-108 in Phase 2 Trial in Ovarian and Endometrial Cancers
6. AEterna Zentaris to Further Develop Three Follow-up Multi-targeted Cytotoxic Candidates to AEZS-112 as Potential Novel Cancer Treatment
7. AEterna Zentaris Announces Outcome of Managements Strategic Review
8. AEterna Zentaris to Present at Upcoming UBS Global Life Sciences Conference in New York
9. AEterna Zentaris completes management team with the appointment of Chief Medical Officer
10. BioCryst Reports Fourth Quarter and Year End 2007 Financial Results and Corporate Update
11. MiddleBrook Pharmaceuticals Reports Fourth Quarter and Full Year 2007 Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/22/2014)... 2014  ( www.competitivehealth.com ) — Competitive Health is ... review and advocacy service, has signed an agreement to ... discount health services marketplace. 63% of Americans ... they expected to pay. As part of an ongoing ... Savings is pleased to offer medical bill review and ...
(Date:12/22/2014)... ITRA Global, one of the largest ... real estate, has further expanded its global reach with ... Brisbane, Western Australia, reports Mylinda Vick, CCIM, Chairman of ... Global / ACORPP (Australian Corporate Property and Projects) , ... property services to a wide range of clients in ...
(Date:12/19/2014)... December 19, 2014 Bioject Medical ... and manufacturer of needle-free injection technology, today announced ... Immunomic Therapeutics, Inc. (“ITI”) for ITI to use ... its LAMP™ vaccine platform. , In the ... Worldwide license to the Biojector®-2000 that triggers based ...
(Date:12/19/2014)... 2014 BioPlus Specialty Pharmacy ... the promotion of Nick Maroulis, Pharm.D. to the newly ... , In this position, Dr. Maroulis will continue ... the directors of our multi-site pharmacies as the company ... and during that time he has served in many ...
Breaking Biology Technology:WellCard Savings Announces CoPatient Medical Bill Review Service for Members 2ITRA Global Continues International Expansion in Perth and Brisbane, Australia 2Bioject and Immunomic Therapeutics Enter into an Agreement for License of Needle-Free Technology for LAMP-vax Vaccines 2Bioject and Immunomic Therapeutics Enter into an Agreement for License of Needle-Free Technology for LAMP-vax Vaccines 3BioPlus Specialty Pharmacy Promotes Dr. Nick Maroulis to Vice President of Specialty Pharmacy Services 2
... ... Process Optimization Using At-Line Particle Characterization”, will be presented on December 2, 2009. ... the design space and optimize a series of roller compaction runs while varying raw ... ...
... 19 Danish Prince Joachim inaugurated the DONG Energy ... Wednesday, November 18. The facility is one of the ... Genencor,s Accellerase enzymes are used in the plant,s innovative ... of Danisco, was the first to market with commercial ...
... , , BETHESDA, Md., ... innovator in biotechnology for diabetes therapy, and a provider of ... pharmaceutical companies, announced today it closed the previously reported $6.3 ... of its common stock and warrants to purchase up to ...
Cached Biology Technology:Roller Compaction Process Optimization Using At-Line Particle Characterization 2DONG Energy and Inbicon Inaugurate One of the World's Largest Demo Plants for 2nd Generation Biofuel 2Spherix Announces the Closing of $6.3 Million Registered Direct Offering 2Spherix Announces the Closing of $6.3 Million Registered Direct Offering 3
(Date:12/10/2014)...  Valencell, a leader in performance biometric data sensor ... from its licensees for highly accurate, clinically validated biometric ... coming from fitness and health sectors, but first responders/military ... is only as useful as the biometric data it ... in long-term mass consumer adoption of wearable products," said ...
(Date:12/10/2014)... December 9, 2014   ... Platform   Jifflenow, ... scheduling solutions for business-to-business (B2B) events, today announced ... in mobile near-field communication (NFC), Bluetooth low energy ... (Logo: http://photos.prnewswire.com/prnh/20140612/691055) , Jifflenow will integrate ...
(Date:12/3/2014)... Calif. , Dec. 2, 2014   ... globally deployed, innovative test solutions for military, aerospace, ... newest version of its successful TS-900 PXI ... performance and features of high-end systems to customers ... outstanding value compared to traditional ATE. ...
Breaking Biology News(10 mins):Wearable Technology Products Demand Highly Accurate Biometric Technology 2Jifflenow And ITN International Bring Cutting-Edge Badge Scanning Technology To B2B Events 2Jifflenow And ITN International Bring Cutting-Edge Badge Scanning Technology To B2B Events 3Marvin Test Solutions Brings New Capabilities to PXI-Based Semiconductor Test with TS-960 2Marvin Test Solutions Brings New Capabilities to PXI-Based Semiconductor Test with TS-960 3
... Harbor Laboratory (CSHL) have discovered how a protein long ... actually triggers this process in cells. The ... enzyme that attaches phosphate molecules to other proteins to ... DDK performs this operation, called phosphorylation, on a protein ...
... in Montreal, made this discovery Montral, January ... researcher at the Institut de recherches cliniques de Montral (IRCM), ... of visual nerves towards the brain. Their findings have been ... Neuroscience . The research was conducted in collaboration with Dr. ...
... traps deep in the Sumatran jungle have captured first-time images ... unique insight into the elusive tiger,s behaviour. After a ... researchers seeking to record tigers in the Sumatran jungle caught ... stopped to sniff and check out the camera trap. ...
Cached Biology News:CSHL scientists uncover role of protein critical for activating DNA replication 2Discovery of a new molecular mechanism that guides visual nerves towards the brain 2Camera traps yield first-time film of tigress and cubs 2Camera traps yield first-time film of tigress and cubs 3
... formulated specifically for Alkaline Phosphatase conjugates. ... activity for both the enzyme and the ... This product has been chemically engineered ... a longer shelf life, resistance to various ...
... The PATH™ Protein Microarray Slide features ... immunoassays. The,PATH™ Slide is the first ... many benefits of nitrocellulose in a ... excellent signal-to-noise ratios. ,The PATH™ ...
... Cassettes facilitate the hybridization of DNA or ... 25mm x 75mm glass slides. The proprietary ... correct for poor flatness, as is often ... low volume chamber (67uL analytical cavity volume) ...
... Mouse monoclonal [3D12] to Lambda Free ... Mixture of light chains of human ... for independent constantly expressed epitope of ... dimer forms of free lambda chains ...
Biology Products: